Alefacept for alopecia areata

Archives of Dermatology

Volumn 141, Issue 12, 2005, Pages 1513-1516

  Heffernan, Michael P ^a   Hurley, Maria Yadira ^b   Martin, Kathleen S ^c   Smith, David I ^a   Anadkat, Milan J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEFACEPT; CORTICOSTEROID; CYCLOSPORIN; DIPHENCYPRONE; FLUOCINOLONE ACETONIDE; PREDNISONE; RETINOIC ACID; SALAZOSULFAPYRIDINE; SQUARIC ACID DIBUTYL ESTER; TACROLIMUS; TRIAMCINOLONE ACETONIDE;

ADOLESCENT; ADULT; ALOPECIA AREATA; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL TRIAL; CONTACT DERMATITIS; DRUG ERUPTION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT WITHDRAWAL;

ADOLESCENT; ADULT; ALOPECIA AREATA; DERMATOLOGIC AGENTS; FEMALE; HAIR; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; RECOMBINANT FUSION PROTEINS; TREATMENT OUTCOME;

EID: 29144523203     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.141.12.1513     Document Type: Article

References (22)

1. Freyschmidt-Paul P, Happle R, McElwee KJ, Hoffman R. Alopecia areata: treatment of today and tomorrow. J Investig Dermatol Symp Proc. 2003;8:12-17.
2. Madani S, Shapiro J. Alopecia areata update. J Am Acad Dermatol. 2000;42:549-570.
3. Olsen EA, Carson SC, Turney EA. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. Arch Dermatol. 1992;128:1467-1473.
4. Shapiro J, Lui H, Tron V, Ho V. Systemic cyclosporine and low-dose prednisone in the treatment of chronic severe alopecia areata: a clinical and immunopathologic evaluation. J Am Acad Dermatol. 1997;36:114-117.
5. Gupta AK, Ellis CN, Cooper KD, et al. Oral cyclosporine for the treatment of alopecia areata: a clinical and immunohistochemical analysis. J Am Acad Dermatol. 1990;22(2 pt 1):242-250.
6. Gilhar A, Ullmann Y, Berkutzki T, Assy B, Kalish RS. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp expiants on SCID mice. J Clin Invest. 1998;101:62-67.
7. Hull SM, Norris JF. Diphencyprone in the treatment of long-standing alopecia areata. Br J Dermatol. 1988;119:367-374.
8. Shong YK, Kim JA. Vitiligo in autoimmune thyroid disease. Thyroidology. 1991;3:89-91.
9. Paus R, Slominski A, Czarnetzki BM. Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med. 1993;66:541-554.
10. Hacham-Zadeh S, Brautbar C, Cohen CA, Cohen T. HLA and alopecia areata in Jerusalem. Tissue Antigens. 1981;18:71-74.
11. Hordinsky MK, Hallgren H, Nelson D, Filipovich AH. Familial alopecia areata: HLA antigens and autoantibody formation in an American family. Arch Dermatol. 1984;120:464-468.
12. scid mice. Arch Dermatol. 2002;138:916-922.
13. Majeau GR, Meier W, Jimmo B, Kioussis D, Hochman PS. Mechanism of lymphocyte function-associated molecule 3-Ig fusion proteins inhibition of T cell responses: structure/function analysis in vitro and in human CD2 transgenic mice. J Immunol. 1994;152:2753-2767.
14. McElwee KJ, Spiers EM, Oliver RF. Partial restoration of hair growth in the DEBR model for Alopecia areata after in vivo depletion of CD4+ T cells. Br J Dermatol. 1999;140:432-437.
15. Hoffmann R, Wenzel E, Huth A, et al. Cytokine mRNA levels in Alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone. J Invest Dermatol. 1994;103:530-533.
16. Wingren AG, Parra E, Varga M, et al. T cell activation pathways: B7, LFA-3, and ICAM-1 shape unique T cell profiles. Crit Rev Immunol. 1995;15:235-253.
17. Gordon KB, Vaishnaw AK, O'Gorman J, Haney J, Menter A; Alefacept Clinical Study Group. Treatment of psoriasis with alefacept: correlation of clinical improvement with reductions of memory T-cell counts. Arch Dermatol. 2003;139:1563-1570.
18. van der Steen PH, van Baar HM, Happle R, Boezeman JB, Perret CM. Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenone. J Am Acad Dermatol. 1991;24(2 pt 1):227-230.
19. McElwee KJ, Freyschmidt-Paul P, Zoller M, Hoffman R. Alopecia areata susceptibility in rodent models. J Investig Dermatol Symp Proc. 2003;8:182-187.
20. Gottlieb AB, Casale TB, Frankel E, et al. CD4+ T-cell-directed antibody responses are maintained in patients with psoriasis receiving alefacept: results of a randomized study. J Am Acad Dermatol. 2003;49:816-825.
21. Chao M, Casaccia-Bonnefil P, Carter B, Chittka A, Kong H, Yoon SO. Neurotrophin receptors: mediators of life and death. Brain Res Brain Res Rev. 1998;26:295-301.
22. Botchkarev VA. Neurotrophins and their role in pathogenesis of alopecia areata. J Investig Dermatol Symp Proc. 2003;8:195-198.